Literature DB >> 6409635

Determination of cardiac and plasma drug levels during long-term amiodarone therapy.

N M Debbas, C Du Cailar, A Sassine, J Derancourt, J G Demaille, P Puech.   

Abstract

A study of plasma and cardiac concentrations of amiodarone during the course of long-term oral therapy was made possible by the improvement of analytical high performance liquid chromatography of plasma and tissue extracts. The plasma level was found to increase linearly with the daily dose of the drug, above a threshold value of c. 1 . 9 mg kg-1 day-1. Similarly, the cardiac content increased linearly with the daily dose, with no threshold, showing that the drug is taken up and accumulated in the cardiac tissue, with no obvious difference between atrial and ventricular samples (P greater than 0 . 05). Both plasma and heart showed no saturation at high drug intake, a justification for increasing the oral intake in severe cases. The linear relationship between tissue and blood concentrations allows a prediction of the cardiac level from a simple and routine blood analysis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6409635     DOI: 10.1111/j.1365-2362.1983.tb00076.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

Review 1.  Clinical pharmacokinetics of amiodarone.

Authors:  R Latini; G Tognoni; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

2.  Alterations to the electrical activity of atrial muscle isolated from the rat heart, produced by exposure in vitro to amiodarone.

Authors:  B J Northover
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

3.  The QT interval: a predictor of the plasma and myocardial concentrations of amiodarone.

Authors:  N M Debbas; C du Cailar; R S Bexton; J G Demaille; A J Camm; P Puech
Journal:  Br Heart J       Date:  1984-03

4.  Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure.

Authors:  J G Cleland; H J Dargie; I N Findlay; J T Wilson
Journal:  Br Heart J       Date:  1987-05

5.  Amiodarone-treated patients with suppressed TSH test are at risk of thyrotoxicosis.

Authors:  M Stäubli; H Studer
Journal:  Klin Wochenschr       Date:  1985-02-15

6.  Benznidazole and amiodarone combined treatment attenuates cytoskeletal damage in Trypanosoma cruzi-infected cardiac cells.

Authors:  Juliana Magalhães Chaves Barbosa; Yasmin Pedra-Rezende; Luíza Dantas Pereira; Tatiana Galvão de Melo; Helene Santos Barbosa; Joseli Lannes-Vieira; Solange Lisboa de Castro; Anissa Daliry; Kelly Salomão
Journal:  Front Cell Infect Microbiol       Date:  2022-08-25       Impact factor: 6.073

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.